ABVC BioPharma, Inc. Repayments of Short-term Debt
ABVC BioPharma, Inc. (ABVC) reported Repayments of Short-term Debt of $691.30 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-12
- ABVC BioPharma, Inc. repayments of short-term debt for the quarter ending 2026-06-30 was $29.65K, a 0.08% increase year-over-year.
- ABVC BioPharma, Inc. repayments of short-term debt for the quarter ending 2026-03-31 was $661.65K, a 2162.05% increase year-over-year.
- ABVC BioPharma, Inc. repayments of short-term debt for the quarter ending 2025-12-31 was $30.12K.
- ABVC BioPharma, Inc. repayments of short-term debt for the quarter ending 2025-09-30 was $31.41K.
- ABVC BioPharma, Inc. repayments of short-term debt for fiscal 2025 was $120.40K, a 313.01% increase from fiscal 2024.
- ABVC BioPharma, Inc. repayments of short-term debt for fiscal 2024 was $29.15K, a 97.08% decline from fiscal 2023.
- ABVC BioPharma, Inc. repayments of short-term debt for fiscal 2023 was $1.00M.
USD
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $691.30K 10-Q · filed 2026-08-12 | $721.42K derived: sum of 3 quarters · filed 2026-08-12 | $752.82K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $661.65K 10-Q · filed 2026-05-18 | $691.77K derived: sum of 2 quarters · filed 2026-05-18 | $723.17K derived: sum of 3 quarters · filed 2026-05-18 | $752.80K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $30.12K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $61.52K derived: sum of 2 quarters · filed 2026-03-03 | $91.15K derived: sum of 3 quarters · filed 2026-08-12 | $120.40K 10-K · filed 2026-03-03 |
| 2025-09-30 | $31.41K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $61.03K derived: sum of 2 quarters · filed 2026-08-12 | $90.28K 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $29.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $58.88K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $29.25K 10-Q · filed 2026-05-18 | |||
| 2024-12-31 | $29.15K 10-K · filed 2026-03-03 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 derived: sum of 3 quarters · filed 2025-04-15 | $1.00M 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $1.00M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.00M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-17 |
TWD
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 12 month |
|---|---|---|
| 2025-03-31 | 937.50K TWD 10-Q · filed 2025-04-30 | |
| 2024-12-31 | 934.37K TWD 10-K · filed 2025-04-15 |